Candriam SCA’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.8M | Sell |
|
|||||
|
2025
Q1 | $11.7M | Buy |
|
|||||
|
2024
Q4 | $17M | Sell |
|
|||||
|
2024
Q3 | $27.4M | Buy |
|
|||||
|
2024
Q2 | $16.9M | Buy |
|
|||||
|
2024
Q1 | $9.19M | Buy |
|
|||||
|
2023
Q4 | $7.68M | Hold |
|
|||||
|
2023
Q3 | $7.38M | Hold |
|
|||||
|
2023
Q2 | $10.6M | Hold |
|
|||||
|
2023
Q1 | $7.59M | Hold |
|
|||||
|
2022
Q4 | $9.95M | Hold |
|
|||||
|
2022
Q3 | $11M | Buy |
|
|||||
|
2022
Q2 | $9.5M | Buy |
|
|||||
|
2022
Q1 | $4.55M | Hold |
|
|||||
|
2021
Q4 | $6.31M | Buy |
|
|||||
|
2021
Q3 | $3.22M | Hold |
|
|||||
|
2021
Q2 | $5M | Buy |
|